Over 2100 Total Lots Up For Auction at Five Locations - NJ 04/25, MA 04/30, NJ Cleansweep 05/02, TX 05/06, NJ 05/08

Elsevier acquires Via Oncology, a leading provider of clinical decision support solutions for oncology professionals

Press releases may be edited for formatting or style | January 23, 2018 Business Affairs

Elsevier's Clinical Solutions group supports health institutions in improving patient outcomes, reducing clinical errors, and optimizing cost and reimbursements. With Via Oncology, Elsevier will continue to broaden its existing portfolio of solutions to create an integrated offering of end-to-end clinical support and active clinical guidance.

"We are pleased that Elsevier has recognized the value of Via Oncology's successful technology, nurtured for more than a decade at UPMC, and will provide new avenues for the company's growth and for improving the lives of patients," said Tal Heppenstall, President of UPMC Enterprises, the commercialization and innovation arm of UPMC. "We share Elsevier's vision of using data and technology to improve the quality and effectiveness of care and expect that we will find additional ways to mutually pursue these goals in the future."

UPMC, a $17 billion healthcare provider and insurer affiliated with the University of Pittsburgh, will continue to be a Via Oncology customer. The Via Oncology chief executive officer, chief medical officer and employees will continue working with the company in Pittsburgh. The acquisition is effective immediately and terms of the agreement are not being disclosed.


About Via Oncology
Via Oncology is a national leader in decision support tools for cancer. The Via Pathways span the continuum of cancer care including workup, diagnostics, treatment, symptom management, survivorship and advance care planning. Via Oncology also supports its cancer center customers through quality reporting, patient education, clinical trial support, nurse triage and medical home tools. The Via Pathways are licensed by cancer centers in 28 states including over 1,500 oncology providers in community, hospital and academic-based settings. Learn more at www.viaoncology.com.


About UPMC
A $17 billion world-renowned health care provider and insurer, Pittsburgh-based UPMC is inventing new models of patient-centered, cost-effective, accountable care. UPMC provides more than $900 million a year in benefits to its communities, including more care to the region's most vulnerable citizens than any other health care institution. The largest nongovernmental employer in Pennsylvania, UPMC integrates 80,000 employees, more than 30 hospitals, 600 doctors' offices and outpatient sites, and a more than 3.2 million-member Insurance Services Division, the largest medical insurer in western Pennsylvania. As UPMC works in close collaboration with the University of Pittsburgh Schools of the Health Sciences, U.S. News & World Report consistently ranks UPMC Presbyterian Shadyside on its annual Honor Roll of America's Best Hospitals. UPMC Enterprises functions as the innovation and commercialization arm of UPMC, and UPMC International provides hands-on health care and management services with partners on four continents. For more information, go to www.upmc.com.

You Must Be Logged In To Post A Comment